Conessine
SIGMA/SML0095 - ≥97% (HPLC)
Synonym: (3β)-N,N-dimethyl-con-5-enin-3-amine; Conessin; NSC 119994; Neriine; Roquessine; Wrightine
CAS Number: 546-06-5
Empirical Formula (Hill Notation): C24H40N2
Molecular Weight: 356.59
EC Number: 208-897-2
MDL Number: MFCD00016752
Linear Formula: C24H40N2
Product Type: Chemical
assay | ≥97% (HPLC) |
color | white to tan |
form | powder |
InChI | 1S/C24H40N2/c1-16-20-8-9- |
InChI key | GPLGAQQQNWMVMM-MYAJQUOBSA |
originator | Abbott |
Quality Level | 100 |
SMILES string | C[C@H]1[C@H]2CC[C@H]3[C@@ |
solubility | ethanol: ≥2 mg/mL |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Conessine is a plant steroid alkaloid that acts as a potent and specific antagonist of histamine H3 receptors (Ki = 5.37 and 24.5 nM for human and rat receptors, respectively). Conessine is 1860-fold selective for H3 over H4 and does not bind to H1 or H2 receptors. The molecule also binds to the human α2C4 adrenergic receptor (pKi = 7.98). |
Features and Benefits: | This compound was developed by Abbott . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
General description: | Conessine is a steroidal alkaloid. It has anti-malarial properties, thus, conessine has been used in treatment of malaria. |
Packaging: | 10, 50 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥97% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |